alexa

GET THE APP

KRAS G-quadruplex Stabilisation By Porphyrin Based Compounds: A Powerful Tool Against Pancreatic Cancer | 99579
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 1337

Journal of Gastrointestinal & Digestive System received 1337 citations as per google scholar report

Journal of Gastrointestinal & Digestive System peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

KRAS G-quadruplex stabilisation by porphyrin based compounds: A powerful tool against pancreatic cancer

International Conference on Gastrointestinal Cancer and Therapeutics & 4th World Congress on Digestive & Metabolic Diseases & 26th Annual Congress on Cancer Science and Targeted Therapies

Rudradip Pattanayak

Jagadis Bose National Science Talent Search, India

Posters & Accepted Abstracts: J Gastrointest Dig Syst

DOI: 10.4172/2161-069X-C8-086

Abstract
KRAS, a frequently mutated proto-oncogene is accountable for almost every type of cancer which can form a G-quadruplex structure in the promoter region. G-quadruplex structures are one of the most important drug targets for modern targeted cancer therapy for their unique structure and specificity. Several synthetic porphyrin-based compounds have been screened as potential KRAS-promoter/G-quadruplex stabilizing ligands, using molecular modeling and docking studies. Two novel porphyrins: Porphyrin-1(Cobalt containing) and Porphyrin-2 (Palladium containing) evidenced high affinity towards KRASpromoter/ G-quadruplex. In silico results were further validated in vitro, using techniques like fluorescence and CD spectroscopy. As KRAS mutation is prevalent in pancreatic cancer, the efficacy of these ligands against human pancreatic ductal carcinoma cell line PANC-1 and MiaPaCa-2 were examined. Both Porphyrin-1 and Porphyrin-2 exhibited significant cytotoxicity towards both cell lines, accompanied by the induction of apoptosis, inhibition to colony forming abilities and migratory properties of cancer cells. These two porphyrins block metastasis via blocking of Epithelial to mesenchymal transition. Moreover, in vivo studies confirmed, both porphyrin compounds to be very much effective against mice solid tumor model but with significant low toxicity against normal swiss albino mice. Interestingly the expression of KRAS protein in porphyrin-treated PANC-1 and MiaPaCa-2 cells was drastically reduced at both protein and RNA levels. Thus interaction of porphyrin-based ligands with G-quadruplex. DNA at the promoter region of KRAS might be responsible to inhibit the proliferation of pancreatic cancer cells which may have significant implication in cancer research.
Biography

Rudradip Pattanayak has completed his Master’s degree from the Department of Biochemistry, University of Calcutta, India. He is the final year student of PhD under the guidance of Prof Maitree Bhattacharyya in the Department of Biochemistry, University of Calcutta in collaboration with Jagadis Bose National Science Talent Search, India. He has published 7 research papers in reputed journals. He is currently working on G-quadruplex mediated regulation of oncogenes.

E-mail: [email protected]

 

Top